Related Experiment Video
Updated: May 6, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice
Jong-Kook Lee1, Seong-Cheol Park, Kyung-Soo Hahm
1Research Center for Proteinaceous Materials (RCPM), Chosun University, Kwangju 501-759, Republic of Korea.
Abstract:
In response to the growing problem of multidrug-resistant pathogenic microbes, much attention is being paid to naturally occurring and synthetic antimicrobial peptides (AMPs) and the effects of their structural modification. Among these modifications, amino acid substitution is a simple approach to enhancing biological activity and reducing cytotoxicity. An earlier study indicated that HPA3, an analog of HP (2-20) derived from the N-terminus of Helicobacter pylori ribosomal protein L1, forms large pores and shows considerable cytotoxicity. However, HPA3P, in which a proline (Pro) is substituted for glutamic acid (Glu) at position 9 of HPA3, shows markedly less cytotoxicity. This may be attributable to the presence of a Pro-kink into middle of the HPA3P structure within the membrane environment. Unfortunately, HPA3P is not an effective antibacterial agent in vivo. We therefore designed a helix-PXXP-helix structure (HPA3P2), in which Pro was substituted for the Glu and phenylalanine (Phe) at positions 9 and 12 of HPA3, yielding a molecule with a flexible central hinge. As compared to HPA3P, HPA3P3 exhibited dramatically increased antibacterial activity in vivo. ICR mice infected with clinically isolated multidrug-resistant Pseudomonas aeruginosa showed 100% survival when administered one 0.5-mg/kg dose of HPA3P2 or three 0.1-mg/kg doses of HPA3P2. Moreover, in a mouse model of septic shock induced by P. aeruginosa LPS, HPA3P2 reduced production of pro-inflammatory mediators and correspondingly reduced lung (alveolar) and liver tissue damage. The changes in HPA3 behavior with the introduction of Pro likely reflects alterations of the mechanism of action: i) HPA3 forms pores in the bacterial cell membranes, ii) HPA3P permeates the cell membranes and binds to intracellular RNA and DNA, and iii) HPA3P2 acts on the outer cellular membrane component LPS. Collectively, these results suggest HPA3P2 has the potential to be an effective antibiotic for use against multidrug-resistant bacterial strains.
Insights
A modified antimicrobial peptide, HPA3P2, shows significant effectiveness against multidrug-resistant Pseudomonas aeruginosa in vivo. This new peptide reduces inflammation and tissue damage, offering potential as a novel antibiotic treatment.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Multidrug-resistant microbes pose a significant global health threat.
- Antimicrobial peptides (AMPs) are a promising alternative, with structural modifications enhancing efficacy and reducing toxicity.
- HPA3, a modified AMP, exhibits cytotoxicity, while HPA3P shows reduced toxicity but limited in vivo antibacterial activity.
Purpose of the Study:
- To design and evaluate a novel antimicrobial peptide, HPA3P2, with enhanced antibacterial activity and reduced cytotoxicity.
- To investigate the mechanism of action of HPA3P2 against multidrug-resistant bacteria.
Main Methods:
- Design of HPA3P2 with a helix-PXXP-helix structure via amino acid substitution (Pro at positions 9 and 12).
- In vivo efficacy testing in ICR mice infected with multidrug-resistant Pseudomonas aeruginosa.
- Evaluation of HPA3P2 in a mouse model of septic shock induced by P. aeruginosa LPS.
Main Results:
- HPA3P2 demonstrated 100% survival in mice infected with multidrug-resistant P. aeruginosa at low doses.
- HPA3P2 significantly reduced pro-inflammatory mediators and tissue damage in a septic shock model.
- Mechanism of action involves targeting the lipopolysaccharide (LPS) on the bacterial outer membrane.
Conclusions:
- HPA3P2 exhibits potent in vivo antibacterial activity against multidrug-resistant P. aeruginosa.
- HPA3P2 demonstrates anti-inflammatory and tissue-protective effects.
- HPA3P2 represents a promising therapeutic candidate for combating multidrug-resistant bacterial infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial DNA Synthesis

